Novel α-Actinin 2 Variant Associated With Familial Hypertrophic Cardiomyopathy and Juvenile Atrial Arrhythmias
Author(s) -
Francesca Girolami,
Maria Iascone,
Benedetta Tomberli,
Sara Bardi,
Matteo Benelli,
Giuseppina Marseglia,
Chiara Pescucci,
Laura Pezzoli,
Maria Elena Sana,
Cristina Basso,
Nicola Marziliano,
Piera Angelica Merlini,
Alessandra Fornaro,
Franco Cecchi,
Francesca Torricelli,
Iacopo Olivotto
Publication year - 2014
Publication title -
circulation cardiovascular genetics
Language(s) - English
Resource type - Journals
eISSN - 1942-325X
pISSN - 1942-3268
DOI - 10.1161/circgenetics.113.000486
Subject(s) - hypertrophic cardiomyopathy , sanger sequencing , proband , genetics , exome sequencing , cardiomyopathy , biology , medicine , mutation , heart failure , gene , cardiology
Next-generation sequencing might be particularly advantageous in genetically heterogeneous conditions, such as hypertrophic cardiomyopathy (HCM), in which a considerable proportion of patients remain undiagnosed after Sanger. In this study, we present an Italian family with atypical HCM in which a novel disease-causing variant in α-actinin 2 (ACTN2) was identified by next-generation sequencing.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom